Together, BAFF/BAFF-R antagonism moderates plasma B cells, lowers autoreactive antibodies and immune complexes in circulation, and effectively combats systemic inflammation and tissue damage in SLE (including LN). Here, TNFSF13B is linked to systemic lupus erythematosus.